Clinical Trial Update: Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) [NA]

View source ↗

Summary

Clinical trial completed evaluating an allergen-specific immune signature-directed dietary elimination approach for eosinophilic esophagitis; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Eosinophilic Esophagitis | NA | Status: COMPLETED | Results posted: 2019-04-02